1. Screening Libraries
  2. Histone Modification Research Compound Library

Histone Modification Research Compound Library

Cat. No.: HY-L024
Library Contents: XLSX PDF

A unique collection of 158 bioactive compounds targeting histone modification for high throughput screening (HTS) and high content screening (HCS).

Histone Modification Research Compound Library
Size (Pre-dissolved DMSO or Solid) Price Stock
30 μL/well (10 mM solution) Get quote In-stock
50 μL/well (10 mM solution) Get quote In-stock
100 μL/well (10 mM solution) Get quote In-stock
250 μL/well (10 mM solution) Get quote In-stock

Please contact us at

[email protected]

Top Publications Citing Use of Products
  • Description

  • Product Details

  • Composition

  • Contents

  • Documentation

Description
& Advantages

•   A unique collection of 158 bioactive compounds for high throughput screening (HTS) and high content screening (HCS).

•   Targets include Epigenetic Reader Domain, HDAC, Histone Acetyltransferase, Histone Demethylase, Histone Methyltransferase, Sirtuin, etc.

•   A useful tool for the research of the regulation of histone modification and the corresponding diseases.

•   Bioactivity and safety confirmed by preclinical research and clinical trials. Some inhibitors have been approved by FDA.

•   Structurally diverse, medicinally active, and cell permeable.

•   More detailed compound information with structure, IC50, and brief introduction.

•   NMR and HPLC validated to ensure high purity and quality.

•   All compounds are in stock and continuously updated.

Product Details
Formulation:
A collection of 158 histone modification related compounds supplied as pre-dissolved DMSO solutions or Solid
Container:
96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
Storage:
-80°C
Shipping:
Blue ice
Composition

Histone Modification Research Compound Library

Source: MedChem Express

Contents of Histone Modification Research Compound Library

Plate layout: HY-L024-1

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Sodium Butyrate Valproic acid 3-TYP Daminozide Valproic acid (sodium salt) Tranylcypromine (hemisulfate) Sodium phenylbutyrate IOX1 BG45 Droxinostat Empty
b Empty MS049 EX-527 Vorinostat CI-994 ACY-738 UF010 C-7280948 CPI-455 Santacruzamate A BRD73954 Empty
c Empty Fisetin MS023 GSK-LSD1 Dihydrochloride AS8351 ITSA-1 LMK-235 PCI-34051 SGC707 Trichostatin A ORY-1001(trans) Empty
d Empty SR-4370 M344 JIB-04 MC1568 HPOB Belinostat PFI-3 NKL 22 Scriptaid A-366 Empty
e Empty Tubastatin-A CeMMEC1 UNC 669 Pimelic Diphenylamide 106 RG2833 BML-210 BCI-121 MG 149 HDAC8-IN-1 PFI-1 Empty
f Empty Anacardic Acid ML324 Panobinostat BI-7273 BI-9564 Pracinostat Cambinol RGFP966 Remodelin (hydrobromide) GSK2879552 Empty
g Empty OSS_128167 Curcumin EED226 Tenovin-1 RVX-208 GSK2801 Tubastatin A (Hydrochloride) MI-3 MI-2 EED inhibitor-1 Empty
h Empty Entinostat KG-501 Dacinostat PFI-4 EPZ015866 HLCL-61 (hydrochloride) MS436 NI-57 WDR5-0103 CPI-637 Empty

Plate layout: HY-L024-2

1 2 3 4 5 6 7 8 9 10 11 12
a Empty WM-1119 GSK-J1 GSK-J2 Tucidinostat EI1 Sirtinol GSK-5959 Salermide Mocetinostat CPI-203 Empty
b Empty JQ-1 (carboxylic acid) AK-1 Bromosporine Tasquinimod GSK6853 BRD4770 UNC0379 I-BET151 GSK-J4 CAY10602 Empty
c Empty GSK 525762A BAY-299 ACY-1215 CUDC-101 GSK1324726A AK-7 SP2509 PLX51107 OF-1 Ginkgolide C Empty
d Empty C646 BET bromodomain inhibitor PF-06726304 4SC-202 (free base) GSK3326595 Tenovin-6 TMP195 (R)-(-)-JQ1 Enantiomer (+)-JQ-1 WT-161 Empty
e Empty Mivebresib Histone Acetyltransferase Inhibitor II Amodiaquin (dihydrochloride dihydrate) Citarinostat Inauhzin UNC0224 BIX-01294 OTX-015 I-BRD9 SRT 1720 (Hydrochloride) Empty
f Empty CUDC-907 SGC-CBP30 UNC0638 TMP269 BI 2536 4-(2-(5-(3,5-Dimethylisoxazol-4-yl)-2-(4-propoxyphenethyl)-1H-benzo[d]imidazol-1-yl)ethyl)morpholine hydrochloride GSK126 GSK503 CPI-169 racemate UNC1215 Empty
g Empty PFI-2 (hydrochloride) EPZ004777 GSK343 UNC0642 AMI-1 OICR-9429 EPZ-5676 UNC1999 EPZ-6438 LLY-507 Empty
h Empty EPZ011989 SGC0946 666-15 UNC0646 AZD5153 (6-Hydroxy-2-naphthoic acid) MM-102 (trifluoroacetate) dBET1 UNC3866 Empty Empty Empty
Documentation

Inquiry Online

Your information is safe with us. * Required Fields.

Product name

 

Salutation

Applicant name *

 

Email address *

Phone number *

 

Organization name *

Country or Region *

 

Requested quantity *

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Histone Modification Research Compound Library
Cat. No.:
HY-L024
Quantity:

Request SDF File

Please enter your email address. We will send your requested SDF file to you as soon as possible.